Company / Cash per Share
Veracyte, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$4.66
FY2025
5-year range
$2.17 / $4.66
FY2021-FY2025
Trend
+42.9%
vs FY2024
Sector context
#54 of 150
Health Care
What the data says
At $4.66, Veracyte, Inc.'s cash per share ranks #54 of 150 in the Health Care sector. Cash per Share has increased for 3 consecutive years, from $2.17 in FY2022 to $4.66 in FY2025.
Based on SEC 10-K filings.
4.66 in FY2025 with a 5-year CAGR of -7.9%.
Improved from $3.01 to $4.66 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +29.1%
- 5-Year CAGR
- -7.9%
- 10-Year CAGR
- -
Sector benchmark
#54 of 150 in Health CareTop 36% of 150This company $4.66 Sector average $27.04
▼
-82.8% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s cash per share has grown for 3 consecutive years.
- In FY2025, cash per share increased 42.9% year-over-year.
- Ranks #54 out of 150 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.66 | +42.9% |
| FY2024 | $3.26 | +8.5% |
| FY2023 | $3.01 | +38.7% |
| FY2022 | $2.17 | -27.1% |
| FY2021 | $2.98 | -57.7% |
| FY2020 | $7.04 | +80.6% |
| FY2019 | $3.90 | +68.8% |
| FY2018 | $2.31 | +130.1% |
| FY2017 | $1.00 | -53.1% |
| FY2016 | $2.14 | +23.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026